Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31
Phase 41

Trial Status

Completed3

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT05409612Phase 3Completed
Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients
Morbid ObesitySevere Obesity
PrincipalinvestigatorStart date: 2022-11-07
NCT01072734Phase 2Completed
Auto-immunity in Lupus Patients After Influenza Vaccine
Systemic Lupus Erythematosus (SLE)
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Assistance Publique - Hôpitaux de Paris

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05409612Phase 3PrincipalInvestigator

Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients

Morbid ObesitySevere Obesity
Completed
NCT02325310Phase 4StudyDirector

Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR

MeaslesMumpsRubella
Completed
NCT01072734Phase 2PrincipalInvestigator

Auto-immunity in Lupus Patients After Influenza Vaccine

Systemic Lupus Erythematosus (SLE)
Completed

All 3 trials loaded